scPharmaceuticals Inc. (SCPH) News

scPharmaceuticals Inc. (SCPH): $7.83

0.14 (+1.82%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter SCPH News Items

SCPH News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

SCPH News Highlights

  • For SCPH, its 30 day story count is now at 4.
  • Over the past 27 days, the trend for SCPH's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest SCPH News From Around the Web

Below are the latest news stories about SCPHARMACEUTICALS INC that investors may wish to consider to help them evaluate SCPH as an investment opportunity.

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BURLINGTON, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (“scPharmaceuticals” or the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that on February 1, 2023, the Compensation Committee of scPharmaceuticals’ board of directors granted inducement equity grants consisting of stock options to purchase an aggregate

Yahoo | February 6, 2023

scPharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

BURLINGTON, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, is scheduled to present virtually at the SVB Securities Global Biopharma Conference, on Thursday, February 16 at 11:20 am ET. Mr. Tucker wi

Yahoo | January 31, 2023

scPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial Update

Commercial launch planned for February 20, 2023BURLINGTON, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that the company is targeting February 20, 2023 as the date for commercial availability of FUROSCIX® (furosemide injection), a proprietary formulation of furosemide delive

Yahoo | January 30, 2023

scPharmaceuticals Inc. (NASDAQ:SCPH) stock most popular amongst private equity firms who own 41%, while individual investors hold 36%

If you want to know who really controls scPharmaceuticals Inc. ( NASDAQ:SCPH ), then you'll have to look at the makeup...

Yahoo | January 10, 2023

scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2022 Earnings Call Transcript

scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2022 Earnings Call Transcript November 12, 2022 Operator: Greetings, and welcome to the scPharmaceuticals Third Quarter 2022 Earnings Call. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Hans Vitzthum. Thank you, Mr. Vitzthum. You may begin. Hans Vitzthum: Thank you, operator. Before […]

Yahoo | December 29, 2022

What Makes scPharmaceuticals, Inc. (SCPH) a New Buy Stock

scPharmaceuticals, Inc. (SCPH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | December 20, 2022

Has scPharmaceuticals (SCPH) Outpaced Other Medical Stocks This Year?

Here is how scPharmaceuticals, Inc. (SCPH) and Syndax Pharmaceuticals (SNDX) have performed compared to their sector so far this year.

Yahoo | December 20, 2022

scPharmaceuticals names Rachael Nokes as CFO

scPharmaceuticals (SCPH) said Monday it appointed Rachael Nokes, SVP of finance, as CFO.Nokes joined the company in 2014 from BG Medicine, a publicly traded medical device company,…

Seeking Alpha | December 19, 2022

scPharmaceuticals Inc. Announces Appointment of Rachael Nokes as Chief Financial Officer

Appointment brings more than 20 years of life sciences finance leadership experience to the CFO roleBURLINGTON, Mass., Dec. 19, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced the appointment of Rachael Nokes as Chief Financial Officer. Ms. Nokes previously served as scPharmaceuticals’ Senior

Yahoo | December 19, 2022

scPharmaceuticals to Participate in the 12th Annual LifeSci Partners Corporate Access Event

BURLINGTON, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, is scheduled to participate in the 12th Annual LifeSci Partners Corporate Access Event, on Monday, January 9 and Tuesday, January 10, 2023,

Yahoo | December 14, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5304 seconds.